Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110576 · ClinicalTrials.gov registry record
Procedure For The Reference Range Study For Absolute MA
A clinical trial, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- 161
- Enrollment target
NCT02110576 is a clinical trial that has completed, run by Haemonetics Corporation. The registered enrollment target is 161 participants.
The verdict
NCT02110576 has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
CLSI guidelines shall be followed to gather data from a minimum of one hundred and twenty normal donors to create reference intervals for various Haemonetics reagents. Venous blood from a minimum of 146 reference subjects shall be tested. Blood from 160 donors will be drawn at the study site to account for aberrant or outlying data excluded for technical or other reasons.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02110576
The ClinicalTrials.gov registry entry for NCT02110576 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Haemonetics Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02110576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02110576 about?
NCT02110576 is a clinical study titled "Procedure For The Reference Range Study For Absolute MA". CLSI guidelines shall be followed to gather data from a minimum of one hundred and twenty normal donors to create reference intervals for various Haemonetics reagents. Venous blood from a minimum of 146 reference subjects shall be tested. Blood from 160 donors will be drawn at the study site to acco...
What is the current status of trial NCT02110576?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2014-05. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02110576?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.